Principally, MDM2 and CDK4 examination allows differentiation of WDLPS from benign adipose tumors while in DDLPS, MDM2 and CDK4 evaluation help to exclude poorly differentiated sarcomas [26]. This evidence concerns the gene MDM2 and sarcoma.